Who we are

Managed by Brandon Capital, Brandon BioCatalyst supports the development and commercialisation of early-stage biomedical discoveries originating from member research organisations, providing both capital and expertise to guide the successful development of new therapies.

Brandon BioCatalyst is a unique collaboration of investors, CSL, government and more than 50 leading medical research institutes and hospitals united by a single purpose: generating cutting edge, next generation medical therapies and technologies to improve health and save lives.

    Technologies, expertise

    50+ Medical research institutes and hospitals

    Operational support

    ACT Government
    NSW Government Health
    Government of South Australia
    Queensland Government
    Victorian Government
    Western Australian Government
    Ministry of Business, Innovation & Employment (MBIE) NZ

    Management

    Brandon Capital

    Independent Governance
    Investors

    Australian Government
    Australian Super
    Hesta
    Host Plus
    TelstraSuper
    CSL

Members

Institute
Heart Research Institute

The Heart Research Institute (HRI) is an internationally recognised research institute that performs cutting-edge cardiovascular research. The main focus of this research is to gain an understanding of the development and progression of atherosclerosis, the dominant cause of cardiovascular disease.

View
Institute
Auckland Cancer Society Research Centre

Since its inception in 1956, the Auckland Cancer Society Research Centre (ACSRC) has published nearly 1,000 papers in international scientific and medical journals, and filed more than 100 patent applications for new anti-cancer drugs.

View
Institute
The Garvan Institute of Medical Research

The Garvan Institute of Medical Research is one of Australia's premier medical research institutes. We see a future where everyone lives a longer, healthier life.

View

Government Partners

Investors

Brandon BioCatalyst's investors are AustralianSuper, HESTA, HOSTPLUS, TelstraSuper, CSL and the Australian Government under its IIF and BTF programs.

Brandon Capital

Brandon Capital manages Brandon BioCatalyst, providing seed and venture capital investment to support the development and international growth of Australian and New Zealand life science companies.

Brandon Capital website